Compare KMX & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMX | TWST |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.2B |
| IPO Year | 2002 | 2018 |
| Metric | KMX | TWST |
|---|---|---|
| Price | $52.16 | $97.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 8 |
| Target Price | $37.18 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 3.8M | 2.0M |
| Earning Date | 04-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ 1.31 | N/A |
| Revenue | ★ $25,881,131,000.00 | $376,572,000.00 |
| Revenue This Year | N/A | $18.91 |
| Revenue Next Year | $1.82 | $15.07 |
| P/E Ratio | $40.39 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $30.40 | $23.30 |
| 52 Week High | $71.99 | $98.40 |
| Indicator | KMX | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 78.82 |
| Support Level | $37.88 | $42.88 |
| Resistance Level | $53.93 | N/A |
| Average True Range (ATR) | 2.56 | 5.84 |
| MACD | -0.00 | 1.69 |
| Stochastic Oscillator | 76.83 | 83.02 |
CarMax sells, finances, and services used and new cars through a chain of over 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.